content

Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Busines

Olympus Corporation announcedย  the opening of a new facility in Westborough,MA, to serve as the global headquarters for its Therapeutic Solutions Division (TSD) and...

Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients

Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care...

Claritas to expand Covid-19 trial to include sepsis treatment

Claritas Pharmaceuticals is set to expand its development programme for R-107 to include the treatment of Covid-19 related sepsis, which is the leading cause...

Leading BioPharma consultancy SmartAnalyst appoints new CEO

SmartAnalyst, an Ashfield Advisory company, part of UDG Healthcare plc., has appointed Sasha Richardson as Chief Executive Officer. With 24 yearsโ€™ experience, most recently as...

IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange platform with Polar, IDBSโ€™ Biopharmaceutical Lifecycle Management platform

IDBS, a leading innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, a pioneer in laboratory IoT, have entered into a strategic partnership to create...

FedEx Distribution of COVID-19 Vaccines Grows, Reaches 100 Million Vaccine Doses Delivered

For more than a year, FedEx has been on the frontlines of the COVID-19 pandemic, delivering pharmaceuticals, personal protective equipment, critical medical supplies and...

Sound Pharmaceuticals to launch NIH-funded Covid-19 oral therapeutic trial

Developed for various neurotologic, neuropsychiatric, and respiratory indications, SPI-1005 is a capsule with a small molecule called ebselen. The latest development comes after Sound Pharmaceuticals...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read